Argent Trust’s Labcorp LH Stock Holding History

Argent Trust’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,676	Closed	-$295K	–	205
2016 Q4	$295K	Sell	2,676 -161	-6%	-$17.9K	0.09%	168
2016 Q3	$335K	Buy	2,837 +400	+16%	+$47.1K	0.1%	159
2016 Q2	$273K	Buy	+2,437	New	+$262K	0.09%	171

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Argent Trust's LH Position: Q1 2017 in Review

Argent Trust sold out of Labcorp (LH) in Q1 2017, closing a stake of 2,676 shares — an estimated $295K sold.

Argent Trust first reported a position in LH in Q2 2016 and held it in 3 quarters. The position peaked at $335K in Q3 2016. 693 funds tracked by Wall St. Rank hold LH as of Q1 2017.

Argent Trust reported no remaining Labcorp position as of Q1 2017 after selling out during the quarter.
Argent Trust sold 2,676 Labcorp shares in Q1 2017, an estimated $295K.
Argent Trust first reported a position in Labcorp in Q2 2016 and held it in 3 quarters.
Argent Trust's Labcorp position peaked at $335K in Q3 2016.
693 funds tracked by Wall St. Rank held Labcorp as of Q1 2017.

Based on Argent Trust's 13F filing for Q1 2017, filed 10 May 2017.